Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery.
Intraoperative floppy iris syndrome (IFIS) is a triad of progressive intraoperative miosis despite preoperative dilation, billowing of a flaccid iris, and iris prolapse toward the incision sites during phacoemulsification surgery for cataract removal. IFIS has been associated with systemic alpha(1)-adrenergic receptor antagonists and other classes of medications for benign prostatic hyperplasia, as well as other systemic disease. The condition is best managed with several surgical and pharmacologic options if anticipated prior to surgery. Such precautions result in excellent surgical and visual acuity outcomes that appear similar to non-IFIS-affected eyes. There is still much to learn about IFIS and its exact causes, as well as a need for agreed upon guidelines that would enable physicians to properly anticipate and successfully manage or even prevent the condition.
Al-Hussaini
Zuhair K
ZK
Department of Urology, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, IL 60611-3008, USA.
McVary
Kevin T
KT
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D002387:Cataract Extraction / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced*; D007499:Iris Diseases / Q000139:chemically induced*; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D053448:Prostatism / Q000188:drug therapy*; D013577:Syndrome
D000317:Adrenergic alpha-Antagonists
J Pharmacol Exp Ther. 2002 Feb;300(2):521-5
11805212
J Cataract Refract Surg. 2006 Nov;32(11):1899-900
17081883
Eur J Pharmacol. 2003 Jun 20;471(2):135-40
12818701
Exp Eye Res. 2000 Jan;70(1):51-60
10644420
J Cataract Refract Surg. 2007 Dec;33(12):2142-3
18053919
J Cataract Refract Surg. 2007 Jan;33(1):170-1
17189820
Urol Clin North Am. 1995 May;22(2):375-86
7539182
Br J Clin Pharmacol. 2001 Aug;52(2):151-7
11488771
J Cataract Refract Surg. 2005 Dec;31(12):2240-1; author reply 2241
16473184
Curr Opin Ophthalmol. 2009 Jan;20(1):37-41
19077827
Acta Ophthalmol Scand. 2005 Oct;83(5):624-6
16188009
Mol Pharmacol. 1995 Aug;48(2):250-8
7651358
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):271-6
2876390
Br J Urol. 1975 Apr;47(2):193-202
1148621
J Cataract Refract Surg. 2003 Dec;29(12):2366-71
14709298
Surgeon. 2008 Aug;6(4):207-9
18697362
Cell Tissue Res. 1998 Sep;293(3):435-44
9716733
J Cataract Refract Surg. 2007 Jan;33(1):170
17189819
Curr Eye Res. 1998 May;17(5):541-5
9617550
Br J Urol. 1982 Oct;54(5):530
6184107
Br J Urol. 1978 Dec;50(7):551-4
88984
Br J Pharmacol. 2002 Feb;135(3):600-8
11834607
Drugs. 2002;62(1):135-67
11790159
J Cataract Refract Surg. 2008 Jul;34(7):1201-9
18571090
BJU Int. 2005 Sep;96(4):572-7
16104912
JAMA. 2009 May 20;301(19):2044-5
19454645
Urology. 2004 Apr;63(4):709-15
15072886
J Cataract Refract Surg. 2006 Oct;32(10):1611-4
17010855
J Cataract Refract Surg. 2007 Apr;33(4):580-2
17397728
Surv Ophthalmol. 2006 Sep-Oct;51(5):501-12
16950249
Eur J Ophthalmol. 2007 Nov-Dec;17(6):909-13
18050116
J Cataract Refract Surg. 2007 Jun;33(6):1110-2
17531711
Naunyn Schmiedebergs Arch Pharmacol. 1996 Dec;354(6):765-72
8971737
Urology. 2001 Oct;58(4):508-16
11597528
Eur Urol. 1996;29(2):155-67
8647141
Urology. 1981 Jun;17(6):542-6
6166111
Urology. 1998 Jun;51(6):861-72
9609620
Rev Urol. 2003;5 Suppl 4:S42-7
16985963
Brain Res Dev Brain Res. 1995 Nov 21;89(2):309-13
8612334
JAMA. 2009 May 20;301(19):1991-6
19454637
Eye (Lond). 2007 Mar;21(3):331-2
16284599
Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2769-75
8393846
J Cataract Refract Surg. 2005 Apr;31(4):664-73
15899440
Mol Cell Biochem. 2003 Nov;253(1-2):71-88
14619958
Ophthalmology. 2007 May;114(5):957-64
17467530
Br J Urol. 1992 Nov;70 Suppl 1:2-9
1281728
J Urol. 1982 Oct;128(4):836-9
6183460
J Pharmacol Exp Ther. 1997 Jun;281(3):1272-83
9190863
J Urol. 1998 Sep;160(3 Pt 1):937-43
9720591
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):880-6
10711708
Eye (Lond). 2007 Mar;21(3):443-4
17057648
J Cataract Refract Surg. 2007 May;33(5):927-8
17466877
J Cataract Refract Surg. 2008 May;34(5):835-41
18471643
J Auton Nerv Syst. 1994 Dec 15;50(2):139-50
7884154
Am J Physiol. 1996 Dec;271(6 Pt 2):H2469-76
8997307
Eye (Lond). 2007 Sep;21(9):1241-2
17603467
J Urol. 1993 Dec;150(6):2002-6
8230553
J Cataract Refract Surg. 2006 Oct;32(10):1777
17010888
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3766-71
16936084
J Cataract Refract Surg. 2005 Dec;31(12):2241; author reply 2241
16473190
J Urol. 1993 Aug;150(2 Pt 1):546-51
7686987
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1437-43
8641846
Br J Pharmacol. 1990 Jul;100(3):401-6
2390667
Br J Pharmacol. 1999 Jul;127(6):1367-74
10455286
Br J Pharmacol. 1996 Mar;117(6):1277-85
8882626
Arch Int Pharmacodyn Ther. 1987 May;287(1):5-15
2820326
J Cataract Refract Surg. 2007 Oct;33(10):1826-7
17889787
J Cataract Refract Surg. 2006 Oct;32(10):1603-5
17010853
Nihon Hinyokika Gakkai Zasshi. 1985 Mar;76(3):325-37
2411986
J Ocul Pharmacol Ther. 2003 Jun;19(3):255-63
12828843
Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):346-53
16489448
Br J Ophthalmol. 2007 Jan;91(1):40-2
16943229
J Cataract Refract Surg. 2008 Dec;34(12):2153-62
19027575
Eur Urol. 1999;36 Suppl 1:35-41; discussion 65
10393471
J Cataract Refract Surg. 2006 Apr;32(4):547
16698457
J Cataract Refract Surg. 2007 Nov;33(11):1997-8
17964415
Brain Res Mol Brain Res. 1999 Jan 8;63(2):254-61
9878769
J Ocul Pharmacol. 1988 Winter;4(4):303-10
2907754
Urology. 1995 Mar;45(3):406-13
7533452
Mol Vis. 2003 Apr 09;9:103-9
12692512
J Cataract Refract Surg. 2007 Jul;33(7):1227-34
17586379